MARKET

NAOV

NAOV

NanoVibronix Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.410
+0.500
+26.18%
Pre Market: 2.380 -0.03 -1.24% 07:33 07/30 EDT
OPEN
2.710
PREV CLOSE
1.910
HIGH
2.989
LOW
2.310
VOLUME
273.14K
TURNOVER
--
52 WEEK HIGH
3.750
52 WEEK LOW
0.5351
MARKET CAP
58.10M
P/E (TTM)
-3.4448
1D
5D
1M
3M
1Y
5Y
Why Is NanoVibronix's Stock Surging Today?
NanoVibronix, Inc. (NASDAQ: NAOV) shares are trading higher after the company announced it received registration approval for UroShield from TGA Australia.
Benzinga · 15h ago
QFIN, DFH, BON among mid-day movers
Gainers: Intec Pharma (NASDAQ:NTEC) +61%. LendingClub Corporation (NYSE:LC) +55%. NanoVibronix (NASDAQ:NAOV) +36%. Golden Star Resources (NYSE:GSS) +28%. Dream Finders Homes (NASDAQ:DFH) +17%. E-Home Household Service Holdings (NASDAQ:EJH) +17%. Tempur Sea...
Seekingalpha · 18h ago
BRIEF-NanoVibronix Gets Registration Approval For UroShield From TGA Australia
reuters.com · 18h ago
NanoVibronix, Intec Pharma leads healthcare gainers; Annovis Bio, Atreca among major losers
Gainers: NanoVibronix NAOV +49%, Intec Pharma (NASDAQ:NTEC) +31%, Cocrystal Pharma COCP +17%, Burning Rock Biotech (NASDAQ:BNR) +11%, Genetron (NASDAQ:GTH) +8%. Losers: Annovis Bio ANVS -48%, Atreca (NASDAQ:BCEL) -35%, Forward Pharma (NASDAQ:FWP) -21%, Cle...
Seekingalpha · 20h ago
Top Midday Gainers
MT Newswires · 21h ago
NanoVibronix Receives Registration Approval For UroShield From TGA Australia
Signs Agreement with DukeHill Healthcare for Distribution of UroShield® and PainShield® in Australia NanoVibronix, Inc., (NASDAQ:NAOV), a Healthcare device company that produces the UroShield®
Benzinga · 22h ago
NOK, TAL and COCP among pre market gainers
LendingClub (NYSE:LC) +38% on Q2 earnings. Cocrystal Pharma (NASDAQ:COCP) +26% SARS-CoV-2 3CL protease lead CDI-45205 demonstrates Broad-Spectrum activity against the SARS-CoV-2 Delta and Gamma Variants Flora Growth (NASDAQ:FLGC) +20%. Acer Therapeutics (N...
Seekingalpha · 22h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Benzinga · 23h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NAOV. Analyze the recent business situations of NanoVibronix Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NAOV stock price target is 10.50 with a high estimate of 10.50 and a low estimate of 10.50.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 1.15M
% Owned: 4.78%
Shares Outstanding: 24.11M
TypeInstitutionsShares
Increased
6
200.62K
New
5
359.36K
Decreased
1
194.60K
Sold Out
3
928.28K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Chairman/Director
Christopher Fashek
President
William Stern
Chief Executive Officer/Director
Brian Murphy
Chief Financial Officer
Stephen Brown
Other/Director
Harold Jacob
Director
Martin Goldstein
Independent Director
Michael Ferguson
Independent Director
Thomas Mika
No Data
About NAOV
NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.

Webull offers kinds of NanoVibronix Inc stock information, including NASDAQ:NAOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NAOV stock methods without spending real money on the virtual paper trading platform.